TICAVIC 90 TABLET

Ticavic 90 Tablet is an oral anticoagulant prescribed to help prevent and manage blood clots in conditions such as deep vein thrombosis (DVT), pulmonary embolism (PE), and clotting risks associated with atrial fibrillation. It contains Rivaroxaban 90mg, a potent factor Xa inhibitor that helps stop clot formation by interrupting the blood coagulation process. This makes Ticavic 90 Tablet an essential option in clinical thromboprophylaxis and long‑term clot prevention under medical supervision.

Ticavic 90 Tablet works by inhibiting Factor Xa, a key enzyme in the coagulation cascade that leads to the formation of fibrin clots. Reducing clotting potential, it helps lower the risk of serious clot‑related complications such as stroke, pulmonary embolism, and recurrent DVT. Being an oral once‑daily tablet, it provides convenient anticoagulant therapy without the need for routine injections.

Ticavic 90 Tablet ensures consistent potency, safety, and reliability. It is widely supplied to hospitals, clinics, and global pharmaceutical markets for dependable anticoagulant care. Patients should follow their doctor’s guidance and have regular monitoring to ensure optimal therapeutic results.

Product Features

• Contains Rivaroxaban 90mg – a direct oral anticoagulant
• Inhibits Factor Xa to prevent blood clot formation
• Used in DVT, PE, and atrial fibrillation clot prevention
• Oral once‑daily convenient dosing
• Quality‑assured pharmaceutical tablet formulation

How It Helps

• Reduces risk of dangerous blood clots
• Helps prevent stroke related to atrial fibrillation
• Aids long‑term thrombosis prevention
• Provides convenient oral anticoagulant therapy